Inhibition of extracellular signal-regulated kinases 1/2 provides neuroprotection in spinal cord ischemia/reperfusion injury in rats: Relationship with the nuclear factor-κB-regulated anti-apoptotic mechanisms

Journal of Neurochemistry

Volumn 114, Issue 1, 2010, Pages 237-246

  Lu, Kang ^a   Liang, Cheng Loong ^a   Liliang, Po Chou ^a   Yang, Chih Hui ^a   Cho, Chung Lung ^b   Weng, Hui Ching ^a   Tsai, Yu Duan ^a   Wang, Kuo Wei ^a   Chen, Han Jung ^a  

^a I SHOU UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cellular inhibitor of apoptosis protein 2; Extracellular signal regulated kinases 1 2; Ischemia reperfusion injury; Nuclear factor B; Spinal cord

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CASPASE 3; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FUNCTIONAL ASSESSMENT; GEL MOBILITY SHIFT ASSAY; IMMUNOREACTIVITY; MALE; MOTOR DYSFUNCTION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BUTADIENES; CASPASE 3; CELL SURVIVAL; ENZYME ACTIVATION; I-KAPPA B PROTEINS; INHIBITOR OF APOPTOSIS PROTEINS; ISCHEMIA; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRILES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPINAL CORD;

RATTUS;

EID: 77953304307     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06747.x     Document Type: Article

References (46)

1. Ahtoniemi T., Goldsteins G., Keksa-Goldsteine V., Malm T., Kanninen K., Salminen A. Koistinaho J. (2007) Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis. Mol. Pharmacol. 71, 30 37.
2. Alessandrini A., Namura S., Moskowitz M. A. Bonventre J. V. (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl Acad. Sci. USA 96, 12866 12869.
3. Baeuerle P. A. Henkel T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141 179.
4. Becker K. J. (1998) Inflammation and acute stroke. Curr. Opin. Neurol. 11, 45 49.
5. Bhakar A. L., Tannis L. L., Zeindler C., Russo M. P., Jobin C., Park D. S., MacPherson S. Barker P. A. (2002) Constitutive nuclear factor-κB activity is required for central neuron survival. J. Neurosci. 22, 8466 8475.
6. Boulton T. G., Nye S. H., Robbins D. J., Ip N. Y., Radziejewska E., Morgenbesser S. D., DePinho R. A., Panayotatos N., Cobb M. H. Yancopoulos G. D. (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65, 663 675.
7. Carter A. B. Hunninghake G. W. (2000) A constitutive active MEK → ERK pathway negatively regulates NF-κB-dependent gene expression by modulating TATA-binding protein phosphorylation. J. Biol. Chem. 275, 27858 27864.
8. Chang L. Karin M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37 40.
9. Chen S. H., Liu S. H., Liang Y. C., Lin J. K. Shiau S. Y. (2000) Death signaling pathway induced by pyrrolidine dithiocarbamate-Cu2+ complex in the cultured rat cortical astrocytes. Glia 31, 249 261.
10. Chu Z. L., McKinsey T. A., Liu L., Gentry J. J., Malim M. H. Ballard D. W. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappa B control. Proc. Natl Acad. Sci. USA 94, 10057 10062.
11. Clemens J. A., Stephenson D. T., Yin T., Smalstig E. B., Panetta J. A. Little S. P. (1998) Drug-induced neuroprotection from global ischemia is associated prevention of persistent but not transient activation of nuclear factor-κB in rats. Stroke 29, 677 682.
12. Culmsee C., Siewe J., Junker V., Retiounskaia M., Schwarz S., Camandola S., El-Metainy S., Behnke H., Mattson M. P. Krieglstein J. (2003) Reciprocal inhibition of p53 and nuclear factor-κB transcriptional activities determines cell survival or death in neurons. J. Neurosci. 23, 8586 8595.
13. Deveraux Q. L., Roy N., Stennicke H. R., Van Arsdale T., Zhou Q., Srinivasula S. M., Alnemri E. S., Salvesen G. S. Reed J. C. (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17, 2215 2223.
14. Funakoshi M., Tago K., Sonoda Y., Tominaga S. Kasahara T. (2001) A MEK inhibitor, PD98059 enhances IL-1-induced NF-κB activation by the enhanced and sustained degradation of IκBα. Biochem. Biophys. Res. Commun. 283, 248 254.
15. Grilli M. Memo M. (1999) Possible role of NF-κB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ. 6, 22 27.
16. Hong S. Y., Yoon W. H., Park J. H., Kang S. G., Ahn J. H. Lee T. H. (2000) Involvement of two NF-κB binding elements in tumor necrosis factor α-, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J. Biol. Chem. 275, 18022 18028.
17. Juurlink B. H. Sweeney M. I. (1997) Mechanisms that result in damage during and following cerebral ischemia. Neurosci. Biobehav. Rev. 21, 121 128.
18. Kim C. H., Kim J. H., Xu J., Hsu C. Y. Ahn Y. S. (1999) Pyrrolidine dithiocarbamate induces bovine cerebral endothelial cell death by increasing the intracellular zinc level. J. Neurochem. 72, 1586 1592.
19. Kim G. M., Xu J., Song S. K., Yan P., Ku G., Xu X. M. Hsu C. Y. (2001) Tumor necrosis factor receptor deletion reduces nuclear factor-κB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J. Neurosci. 21, 6617 6625.
20. Lezoualc'h F., Sagara Y., Holsboer F. Behl C. (1998) High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18, 3224 3232.
21. Love S. (1999) Oxidative stress in brain ischemia. Brain Pathol. 9, 119 131.
22. Lu B., Wang L., Medan D., Toledo D., Huang C., Chen F., Shi X. Rojanasakul Y. (2002) Regulation of Fas (CD95)-induced apoptosis by nuclear factor-κB and tumor necrosis factor-α in macrophages. Am. J. Physiol. Cell Physiol. 283, C831 C838.
23. Lu K., Cho C. L., Liang C. L., Chen S. D., Liliang P. C., Wang S. Y. Chen H. J. (2007) Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1beta expression in spinal cord ischemia/reperfusion injury in rats. J. Thorac. Cardiovasc. Surg. 133, 934 941.
24. Marsala M. Yaksh T. L. (1994) Transient spinal ischemia in the rat: characterization of behavioral and histopathological consequences as a function of the duration of aortic occlusion. J. Cereb. Blood Flow Metab. 14, 526 535.
25. Mattson M. P. (2005) NF-κB in the survival and plasticity of neurons. Neurochem. Res. 30, 883 893.
26. Mattson M. P., Culmsee C., Yu Z. Camandola S. (2000) Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 74, 443 456.
27. Mori T., Wang X., Jung J. C., Sumii T., Singhal A. B., Fini M. E., Dixon C. E., Alessandrini A. Lo E. H. (2002) Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects. J. Cereb. Blood Flow Metab. 22, 444 452.
28. Murray B., Alessandrini A., Cole A. J., Yee A. G. Furshpan E. J. (1998) Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc. Natl Acad. Sci. USA 95, 11975 11980.
29. Namura S., Iihara K., Takami S., Nagata I., Kikuchi H., Matsushita K., Moskowitz M. A., Bonventre J. V. Alessandrini A. (2001) Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc. Natl Acad. Sci. USA 98, 11569 11574.
30. Nozaki K., Nishimura M. Hashimoto N. (2001) Mitogen-activated kinases and cerebral ischemia. Mol. Neurobiol. 23, 1 19.
31. Nurmi A., Lindsberg P. J., Koistinaho M., Zhang W., Juettler E., Karjalainen-Lindsberg M. L., Weih F., Frank N., Schwaninger M. Koistinaho J. (2004) Nuclear factor-κB contributes to infarction after permanent focal ischemia. Stroke 35, 987 991.
32. Piccioli P., Porcile C., Stanzione S., Bisaglia M., Bajetto A., Bonavia R., Florio T. Schettini G. (2001) Inhibition of nuclear factor-κB activation induces apoptosis in cerebellar granule cells. J. Neurosci. Res. 66, 1064 1073.
33. Porcile C., Piccioli P., Stanzione S., Bajetto A., Bonavia R., Barbero S., Florio T. Schettinia G. (2002) Proteosome inhibitors induce cerebellar granular cell death: inhibition of nuclear factor-κB activation. Ann. N Y Acad. Sci. 973, 402 413.
34. Roy N., Deveraux Q. L., Takahashi R., Salvesen G. S. Reed J. C. (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16, 6914 6925.
35. Ryan K. M., Ernst M. K., Rice N. R. Vousden K. H. (2000) Role of NF-κB in p53-mediated programmed cell death. Nature 404, 892 897.
36. Satoh T., Nakatsuka D., Watanabe Y., Nagata I., Kikuchi H. Namura S. (2000) Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci. Lett. 288, 163 166.
37. Sattler R. Tymianski M. (2001) Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24, 107 129.
38. Segal R. A. Greenberg M. E. (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19, 463 489.
39. Stanciu M., Wang Y., Kentor R. et al. (2000) Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary neuron cultures. J. Biol. Chem. 275, 12200 12206.
40. Uren A. G., Pakusch M., Hawkins C. J., Puls K. L. Vaux D. L. (1996) Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl Acad. Sci. USA 93, 4974 4978.
41. Valentine H. L., Amarnath K., Amanath V. Valentine W. M. (2006) Dietary copper enhances the peripheral myelinopathy produced by oral pyrrolidine dithiocarbamate. Toxicol. Sci. 89, 485 494.
42. Wang C. Y., Mayo M. W., Korneluk R. G., Goeddel D. V. Baldwin Jr. A. S. (1998) NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680 1683.
43. Wang X., Wang H., Xu L., Rozanski D. J., Sugawara T., Chang P. H., Trzaskos J. M. Feuerstein G. Z. (2003) Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis. J. Pharmacol. Exp. Ther. 304, 172 178.
44. White B. C., Sullivan J. M., DeGracia D. J., O'Neil R. W., Grossman L. I., Rafols J. A. Krause G. S. (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179, 1 33.
45. Yeh P. Y., Chuang S. E., Yeh K. H., Song Y. C., Ea C. K. Cheng A. L. (2002) Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF-κB activation. Biochem. Pharmacol. 63, 1423 1430.
46. Zhang W., Potrovita I., Tarabin V., Hermann O., Beer V., Weih F., Schneider A. Schwaninger M. (2005) Neuronal activation of NF-κB contributes to cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 25, 30 40.